Bruun JN - Search Results

1

Ormaasen V, Sandvik L, Dudman SG, Bruun JN. Ormaasen V, et al. Among authors: bruun jn. Scand J Infect Dis. 2007;39(1):51-7. doi: 10.1080/00365540600904779. Scand J Infect Dis. 2007. PMID: 17366013

2

A search for optimal criteria in initiating antiretroviral therapy in chronic human immunodeficiency virus infection focusing on CD4 count and HIV RNA.

Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI. Ormaasen V, et al. Among authors: bruun jn. Scand J Infect Dis. 2002;34(12):910-7. doi: 10.1080/0036554021000026957. Scand J Infect Dis. 2002. PMID: 12587624 Clinical Trial.

3

Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection.

Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI. Ormaasen V, et al. Among authors: bruun jn. Scand J Infect Dis. 2003;35(6-7):383-8. doi: 10.1080/00365540310009716. Scand J Infect Dis. 2003. PMID: 12953949 Clinical Trial.

4

Body composition changes in 308 Norwegian HIV-positive patients.

Bergersen BM, Sandvik L, Bruun JN. Bergersen BM, et al. Among authors: bruun jn. Scand J Infect Dis. 2004;36(3):186-91. doi: 10.1080/00365540410019273. Scand J Infect Dis. 2004. PMID: 15119363

5

Serum concentrations of protease inhibitors as predictors of HIV-related clinical events in patients on antiretroviral therapy.

Ormaasen V, Sandvik L, Rudberg N, Bruun JN. Ormaasen V, et al. Among authors: bruun jn. Scand J Infect Dis. 2006;38(8):650-3. doi: 10.1080/00365540600616993. Scand J Infect Dis. 2006. PMID: 16857610

6

Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls.

Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K. Bergersen BM, et al. Among authors: bruun jn. Scand J Infect Dis. 2006;38(8):682-9. doi: 10.1080/00365540500361302. Scand J Infect Dis. 2006. PMID: 16857615

7

[HIV/AIDS--from lethal syndrome to chronic disease].

Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V. Bruun JN, et al. Tidsskr Nor Laegeforen. 2006 Nov 30;126(23):3121-4. Tidsskr Nor Laegeforen. 2006. PMID: 17160119 Free article. Norwegian.

8

Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.

Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, Gundersen SG, Bruun JN. Johannessen A, et al. Among authors: bruun jn. BMC Infect Dis. 2008 Apr 22;8:52. doi: 10.1186/1471-2334-8-52. BMC Infect Dis. 2008. PMID: 18430196 Free PMC article.

9

[Antiviral therapy of HIV infection in adults].

Ormaasen V, Bruun JN. Ormaasen V, et al. Among authors: bruun jn. Tidsskr Nor Laegeforen. 2001 Nov 30;121(29):3414-20. Tidsskr Nor Laegeforen. 2001. PMID: 11826789 Review. Norwegian.

10

Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.

Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN. Bergersen BM, et al. Among authors: bruun jn. Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):731-6. doi: 10.1007/s10096-003-1034-z. Epub 2003 Nov 11. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14610658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page